{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:06:59Z","timestamp":1776391619024,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.ajo.2003.10.034","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T16:48:52Z","timestamp":1072111732000},"page":"S13-S16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"S","title":["Persistency with latanoprost or timolol in primary open-angle glaucoma suspects"],"prefix":"10.1016","volume":"137","author":[{"given":"Gail F","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essy","family":"Mozaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2003.10.034_BIB1","series-title":"Preferred practice patterns of primary open-angle glaucoma suspect","year":"2002"},{"key":"10.1016\/j.ajo.2003.10.034_BIB2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.ajo.2003.10.034_BIB3","first-page":"S237","article-title":"Measuring persistency with drug therapy in glaucoma management","volume":"8","author":"Schwartz","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajo.2003.10.034_BIB4","unstructured":"Daily Health Policy Report. Prescription drugs\u2014study looks at effect of cost on California seniors' prescription drug practices (Nov 1, 2002). Available at: http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?hint=3&DR_ ID=14385. Accessed on October 7, 2003"},{"issue":"Suppl","key":"10.1016\/j.ajo.2003.10.034_BIB5","first-page":"S249","article-title":"Measuring patient persistency with drug therapy using methods for the design and analysis of natural history studies","volume":"8","author":"Johnson","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajo.2003.10.034_BIB6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","article-title":"Survival probabilities (the Kaplan-Meier method)","volume":"317","author":"Bland","year":"1998","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1016\/j.ajo.2003.10.034_BIB7","first-page":"S255","article-title":"Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data","volume":"8","author":"Dasgupta","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajo.2003.10.034_BIB8","doi-asserted-by":"crossref","unstructured":"Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137(Suppl):S3\u2013S12","DOI":"10.1016\/j.ajo.2003.10.035"},{"issue":"Suppl","key":"10.1016\/j.ajo.2003.10.034_BIB9","first-page":"S271","article-title":"Discontinuation rates of topical glaucoma medications in a managed care population","volume":"8","author":"Shaya","year":"2002","journal-title":"Am J Manag Care"},{"issue":"Suppl","key":"10.1016\/j.ajo.2003.10.034_BIB10","first-page":"S262","article-title":"Rates of discontinuation and change of glaucoma therapy in a managed care setting","volume":"8","author":"Spooner","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ajo.2003.10.034_BIB11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0149-2918(03)80074-7","article-title":"Patient persistency with topical prostaglandin therapy in the management of glaucoma","volume":"25","author":"Reardon","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajo.2003.10.034_BIB12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.034_BIB13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.034_BIB14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archopht.1996.01100140137004","article-title":"A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study","volume":"114","author":"Mishima","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.034_BIB15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.034_BIB16","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403013217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403013217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:45:20Z","timestamp":1757594720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939403013217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0002939403013217"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2003.10.034","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistency with latanoprost or timolol in primary open-angle glaucoma suspects","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2003.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}